ScreenerHero
MABMabion S.A.
GPW · PL · Healthcare · Biotechnology · mabion.eu
7.840PLN0.00%Mkt Cap: 32.09M $P/E: —

Mabion S.A., a biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland. It offers drug substance manufacturing, process development, analytics, and cell lin…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap32.09M $
Enterprise Value36.75M $
Revenue (TTM)4.46M $
Gross Profit-4.41M $
Net Income (TTM)-15.86M $
Revenue/Share0.2761 USD
Last Price7.840 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees199
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLMBION00016
Valuation
P/E (Trailing)—
P/E (Forward)-3.54
PEG—
EV/EBITDA-3.81
EV/Revenue8.24
P/S7.20
P/B3.25
EPS (TTM)-3.53
EPS (Forward)-2.22
52W Range
6.70035% of range10.00
52W High10.00 PLN
52W Low6.700 PLN
Profitability
Gross Margin-110.52%
Oper. Margin-200.90%
EBITDA Margin-215.97%
Profit Margin-397.37%
ROE-128.23%
ROA-56.70%
Growth
Revenue Growth68.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.53M $
CapEx (TTM)225.91K $
FCF Margin-106.26%
FCF Yield-14.77%
Net Debt4.66M $
Net Debt/EBITDA-0.48
Balance Sheet
Debt/Equity0.26
Current Ratio0.31
Quick Ratio0.25
Book Value/Sh2.419 PLN
Cash/Share0.4270 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.16.16M
Float11.42M
Insiders32.82%
Institutions0.00%
Technical
SMA 507.463 (+5.0%)
SMA 2007.830 (+0.1%)
Beta0.37
S&P 52W Chg18.16%
Avg Vol (30d)28.42K
Avg Vol (10d)46.46K
Technical Indicators
RSI (14)65.4
MACD0.0523
MACD Signal0.0223
MACD Hist.+0.0300
BB Upper7.719 PLN
BB Middle7.489 PLN
BB Lower7.258 PLN
BB Width6.15%
ATR (14)0.2254 PLN
Vol Ratio (20d)3.07x